What’s New?

Video

Acne patients are benefitting from a robust pipeline with treatments that hold promise for increased efficacy and safety. First-in-class additions to the FDA-approved armamentarium, such as the novel antiandrogen clascoterone (Winlevi; Sun Pharma), give dermatologists and pediatricians new tools to combat this skin condition. Speakers offer insights on matching medications to individual patient needs and controlling costs.

Related Videos
Related Content
From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.

The Week in Review: December 4-8

December 9th 2023
Article
Lifestyle Interventions for ADHD

Lifestyle Interventions for ADHD

May 4th 2022
Podcast
Community Healing During the Mideast War and Other Social Conflicts

Community Healing During the Mideast War and Other Social Conflicts

December 8th 2023
Article
Here's to a Psychedelic Revolution

Here's to a Psychedelic Revolution

April 9th 2022
Podcast
thank you

"Thank You"

December 8th 2023
Article
Researchers performed a double-blind, placebo-controlled pilot study of solriamfetol.

Novel Treatment for Adult ADHD

December 7th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.